Status: current, Sufficiently defined by necessary conditions definition status. Date: 31-Jul 2018. Module: SNOMED CT core module
Descriptions:
| Id | Description | Lang | Type | Status | Case? | Module |
| 3693703010 | Hydrocortisone acetate 15 mg/g and neomycin sulfate 5 mg/g ear or eye ointment | en | Synonym | Active | Entire term case insensitive | SNOMED CT core module |
| 3693705015 | Product containing precisely hydrocortisone acetate 15 milligram/1 gram and neomycin sulfate 5 milligram/1 gram conventional release ear or eye ointment (clinical drug) | en | Fully specified name | Active | Entire term case insensitive | SNOMED CT core module |
| 46757401000001118 | Hydrocortisone 1.5% / Neomycin 0.5% ear/eye ointment | en | Synonym | Active | Entire term case sensitive | SNOMED CT United Kingdom Edition module |
| Outbound Relationships | Type | Target | Active | Characteristic | Refinability | Group | Values |
| Product containing precisely hydrocortisone acetate 15 milligram/1 gram and neomycin sulfate 5 milligram/1 gram conventional release ear or eye ointment | Is a | Compound neomycin preparations | false | Inferred relationship | Existential restriction modifier | ||
| Product containing precisely hydrocortisone acetate 15 milligram/1 gram and neomycin sulfate 5 milligram/1 gram conventional release ear or eye ointment | Is a | Product containing neomycin in topical dosage form | false | Inferred relationship | Existential restriction modifier | ||
| Product containing precisely hydrocortisone acetate 15 milligram/1 gram and neomycin sulfate 5 milligram/1 gram conventional release ear or eye ointment | Has active ingredient | Topical neomycin | false | Inferred relationship | Existential restriction modifier | ||
| Product containing precisely hydrocortisone acetate 15 milligram/1 gram and neomycin sulfate 5 milligram/1 gram conventional release ear or eye ointment | Has active ingredient | Hydrocortisone | false | Inferred relationship | Existential restriction modifier | ||
| Product containing precisely hydrocortisone acetate 15 milligram/1 gram and neomycin sulfate 5 milligram/1 gram conventional release ear or eye ointment | Has active ingredient | Neomycin | false | Inferred relationship | Existential restriction modifier | ||
| Product containing precisely hydrocortisone acetate 15 milligram/1 gram and neomycin sulfate 5 milligram/1 gram conventional release ear or eye ointment | Has active ingredient | Skin anti-infective | false | Inferred relationship | Existential restriction modifier | ||
| Product containing precisely hydrocortisone acetate 15 milligram/1 gram and neomycin sulfate 5 milligram/1 gram conventional release ear or eye ointment | Is a | Product containing hydrocortisone and neomycin | false | Inferred relationship | Existential restriction modifier | ||
| Product containing precisely hydrocortisone acetate 15 milligram/1 gram and neomycin sulfate 5 milligram/1 gram conventional release ear or eye ointment | Has active ingredient | Corticosterone | false | Inferred relationship | Existential restriction modifier | ||
| Product containing precisely hydrocortisone acetate 15 milligram/1 gram and neomycin sulfate 5 milligram/1 gram conventional release ear or eye ointment | Has active ingredient | Adrenal hormone agent | false | Inferred relationship | Existential restriction modifier | ||
| Product containing precisely hydrocortisone acetate 15 milligram/1 gram and neomycin sulfate 5 milligram/1 gram conventional release ear or eye ointment | Has active ingredient | Bactericide | false | Inferred relationship | Existential restriction modifier | ||
| Product containing precisely hydrocortisone acetate 15 milligram/1 gram and neomycin sulfate 5 milligram/1 gram conventional release ear or eye ointment | Has active ingredient | Local anti-infective | false | Inferred relationship | Existential restriction modifier | ||
| Product containing precisely hydrocortisone acetate 15 milligram/1 gram and neomycin sulfate 5 milligram/1 gram conventional release ear or eye ointment | Has manufactured dose form | Conventional release ear or eye ointment | false | Inferred relationship | Existential restriction modifier | ||
| Product containing precisely hydrocortisone acetate 15 milligram/1 gram and neomycin sulfate 5 milligram/1 gram conventional release ear or eye ointment | Has basis of strength substance | Neomycin sulfate | false | Inferred relationship | Existential restriction modifier | 2 | |
| Product containing precisely hydrocortisone acetate 15 milligram/1 gram and neomycin sulfate 5 milligram/1 gram conventional release ear or eye ointment | Count of base of active ingredient | 2 | false | Inferred relationship | Existential restriction modifier | ||
| Product containing precisely hydrocortisone acetate 15 milligram/1 gram and neomycin sulfate 5 milligram/1 gram conventional release ear or eye ointment | Has concentration strength denominator value | 1 | false | Inferred relationship | Existential restriction modifier | 2 | |
| Product containing precisely hydrocortisone acetate 15 milligram/1 gram and neomycin sulfate 5 milligram/1 gram conventional release ear or eye ointment | Has precise active ingredient | Neomycin sulfate | false | Inferred relationship | Existential restriction modifier | 2 | |
| Product containing precisely hydrocortisone acetate 15 milligram/1 gram and neomycin sulfate 5 milligram/1 gram conventional release ear or eye ointment | Has basis of strength substance | Hydrocortisone acetate | false | Inferred relationship | Existential restriction modifier | 1 | |
| Product containing precisely hydrocortisone acetate 15 milligram/1 gram and neomycin sulfate 5 milligram/1 gram conventional release ear or eye ointment | Has concentration strength numerator unit | milligram | true | Inferred relationship | Existential restriction modifier | 1 | |
| Product containing precisely hydrocortisone acetate 15 milligram/1 gram and neomycin sulfate 5 milligram/1 gram conventional release ear or eye ointment | Has concentration strength denominator unit | gram | true | Inferred relationship | Existential restriction modifier | 1 | |
| Product containing precisely hydrocortisone acetate 15 milligram/1 gram and neomycin sulfate 5 milligram/1 gram conventional release ear or eye ointment | Has concentration strength numerator value | 5 | false | Inferred relationship | Existential restriction modifier | 2 | |
| Product containing precisely hydrocortisone acetate 15 milligram/1 gram and neomycin sulfate 5 milligram/1 gram conventional release ear or eye ointment | Has concentration strength numerator value | 15 | false | Inferred relationship | Existential restriction modifier | 1 | |
| Product containing precisely hydrocortisone acetate 15 milligram/1 gram and neomycin sulfate 5 milligram/1 gram conventional release ear or eye ointment | Has concentration strength numerator unit | milligram | true | Inferred relationship | Existential restriction modifier | 2 | |
| Product containing precisely hydrocortisone acetate 15 milligram/1 gram and neomycin sulfate 5 milligram/1 gram conventional release ear or eye ointment | Has concentration strength denominator value | 1 | false | Inferred relationship | Existential restriction modifier | 1 | |
| Product containing precisely hydrocortisone acetate 15 milligram/1 gram and neomycin sulfate 5 milligram/1 gram conventional release ear or eye ointment | Has precise active ingredient | Hydrocortisone acetate | false | Inferred relationship | Existential restriction modifier | 1 | |
| Product containing precisely hydrocortisone acetate 15 milligram/1 gram and neomycin sulfate 5 milligram/1 gram conventional release ear or eye ointment | Has concentration strength denominator unit | gram | true | Inferred relationship | Existential restriction modifier | 2 | |
| Product containing precisely hydrocortisone acetate 15 milligram/1 gram and neomycin sulfate 5 milligram/1 gram conventional release ear or eye ointment | Is a | Product containing hydrocortisone in otic dose form (medicinal product form) | false | Inferred relationship | Existential restriction modifier | ||
| Product containing precisely hydrocortisone acetate 15 milligram/1 gram and neomycin sulfate 5 milligram/1 gram conventional release ear or eye ointment | Is a | Product containing hydrocortisone in ocular dose form (medicinal product form) | false | Inferred relationship | Existential restriction modifier | ||
| Product containing precisely hydrocortisone acetate 15 milligram/1 gram and neomycin sulfate 5 milligram/1 gram conventional release ear or eye ointment | Is a | Product containing neomycin in otic dose form (medicinal product form) | false | Inferred relationship | Existential restriction modifier | ||
| Product containing precisely hydrocortisone acetate 15 milligram/1 gram and neomycin sulfate 5 milligram/1 gram conventional release ear or eye ointment | Is a | Product containing neomycin in ophthalmic dosage form | false | Inferred relationship | Existential restriction modifier | ||
| Product containing precisely hydrocortisone acetate 15 milligram/1 gram and neomycin sulfate 5 milligram/1 gram conventional release ear or eye ointment | Is a | Product containing neomycin in ocular dose form (medicinal product form) | false | Inferred relationship | Existential restriction modifier | ||
| Product containing precisely hydrocortisone acetate 15 milligram/1 gram and neomycin sulfate 5 milligram/1 gram conventional release ear or eye ointment | Is a | Hydrocortisone + Neomycin | false | Inferred relationship | Existential restriction modifier | ||
| Product containing precisely hydrocortisone acetate 15 milligram/1 gram and neomycin sulfate 5 milligram/1 gram conventional release ear or eye ointment | Is a | Product containing only hydrocortisone and neomycin in ocular dose form (medicinal product form) | true | Inferred relationship | Existential restriction modifier | ||
| Product containing precisely hydrocortisone acetate 15 milligram/1 gram and neomycin sulfate 5 milligram/1 gram conventional release ear or eye ointment | Is a | Product containing only hydrocortisone and neomycin in otic dose form (medicinal product form) | true | Inferred relationship | Existential restriction modifier | ||
| Product containing precisely hydrocortisone acetate 15 milligram/1 gram and neomycin sulfate 5 milligram/1 gram conventional release ear or eye ointment | Plays role | Antibacterial therapeutic role | true | Inferred relationship | Existential restriction modifier | ||
| Product containing precisely hydrocortisone acetate 15 milligram/1 gram and neomycin sulfate 5 milligram/1 gram conventional release ear or eye ointment | Has precise active ingredient | Hydrocortisone acetate | true | Inferred relationship | Existential restriction modifier | 2 | |
| Product containing precisely hydrocortisone acetate 15 milligram/1 gram and neomycin sulfate 5 milligram/1 gram conventional release ear or eye ointment | Has precise active ingredient | Neomycin sulfate | true | Inferred relationship | Existential restriction modifier | 1 | |
| Product containing precisely hydrocortisone acetate 15 milligram/1 gram and neomycin sulfate 5 milligram/1 gram conventional release ear or eye ointment | Has basis of strength substance | Neomycin sulfate | true | Inferred relationship | Existential restriction modifier | 1 | |
| Product containing precisely hydrocortisone acetate 15 milligram/1 gram and neomycin sulfate 5 milligram/1 gram conventional release ear or eye ointment | Has basis of strength substance | Hydrocortisone acetate | true | Inferred relationship | Existential restriction modifier | 2 | |
| Product containing precisely hydrocortisone acetate 15 milligram/1 gram and neomycin sulfate 5 milligram/1 gram conventional release ear or eye ointment | Has manufactured dose form | Ocular dose form | true | Inferred relationship | Existential restriction modifier | ||
| Product containing precisely hydrocortisone acetate 15 milligram/1 gram and neomycin sulfate 5 milligram/1 gram conventional release ear or eye ointment | Has active ingredient | Hydrocortisone | false | Inferred relationship | Existential restriction modifier | ||
| Product containing precisely hydrocortisone acetate 15 milligram/1 gram and neomycin sulfate 5 milligram/1 gram conventional release ear or eye ointment | Has manufactured dose form | Conventional release ear or eye ointment | false | Inferred relationship | Existential restriction modifier | ||
| Product containing precisely hydrocortisone acetate 15 milligram/1 gram and neomycin sulfate 5 milligram/1 gram conventional release ear or eye ointment | Count of base of active ingredient | 2 | false | Inferred relationship | Existential restriction modifier | ||
| Product containing precisely hydrocortisone acetate 15 milligram/1 gram and neomycin sulfate 5 milligram/1 gram conventional release ear or eye ointment | Has manufactured dose form | Otic dose form | true | Inferred relationship | Existential restriction modifier | ||
| Product containing precisely hydrocortisone acetate 15 milligram/1 gram and neomycin sulfate 5 milligram/1 gram conventional release ear or eye ointment | Has NHS dm+d (dictionary of medicines and devices) VMP (Virtual Medicinal Product) ontology form and route | ointment.auricular ontology form and route | true | Inferred relationship | Existential restriction modifier | ||
| Product containing precisely hydrocortisone acetate 15 milligram/1 gram and neomycin sulfate 5 milligram/1 gram conventional release ear or eye ointment | Has NHS dm+d (dictionary of medicines and devices) VMP (Virtual Medicinal Product) route of administration | Otic route | true | Inferred relationship | Existential restriction modifier | ||
| Product containing precisely hydrocortisone acetate 15 milligram/1 gram and neomycin sulfate 5 milligram/1 gram conventional release ear or eye ointment | Has NHS dm+d (dictionary of medicines and devices) VMP (Virtual Medicinal Product) ontology form and route | ointment.ophthalmic ontology form and route | true | Inferred relationship | Existential restriction modifier | ||
| Product containing precisely hydrocortisone acetate 15 milligram/1 gram and neomycin sulfate 5 milligram/1 gram conventional release ear or eye ointment | Has NHS dm+d (dictionary of medicines and devices) VMP (Virtual Medicinal Product) route of administration | Ophthalmic route | false | Inferred relationship | Existential restriction modifier | ||
| Product containing precisely hydrocortisone acetate 15 milligram/1 gram and neomycin sulfate 5 milligram/1 gram conventional release ear or eye ointment | Has NHS dm+d (dictionary of medicines and devices) dose form indicator | Continuous dose form indicator | true | Inferred relationship | Existential restriction modifier | ||
| Product containing precisely hydrocortisone acetate 15 milligram/1 gram and neomycin sulfate 5 milligram/1 gram conventional release ear or eye ointment | Has NHS dm+d (dictionary of medicines and devices) controlled drug category | Controlled drug category No Controlled Drug Status | true | Inferred relationship | Existential restriction modifier | ||
| Product containing precisely hydrocortisone acetate 15 milligram/1 gram and neomycin sulfate 5 milligram/1 gram conventional release ear or eye ointment | Is a | Hydrocortisone + Neomycin | true | Inferred relationship | Existential restriction modifier | ||
| Product containing precisely hydrocortisone acetate 15 milligram/1 gram and neomycin sulfate 5 milligram/1 gram conventional release ear or eye ointment | Has active ingredient | Hydrocortisone acetate | false | Inferred relationship | Existential restriction modifier | ||
| Product containing precisely hydrocortisone acetate 15 milligram/1 gram and neomycin sulfate 5 milligram/1 gram conventional release ear or eye ointment | Has manufactured dose form | Ointment | false | Inferred relationship | Existential restriction modifier | ||
| Product containing precisely hydrocortisone acetate 15 milligram/1 gram and neomycin sulfate 5 milligram/1 gram conventional release ear or eye ointment | Has active ingredient | Neomycin | false | Inferred relationship | Existential restriction modifier | ||
| Product containing precisely hydrocortisone acetate 15 milligram/1 gram and neomycin sulfate 5 milligram/1 gram conventional release ear or eye ointment | Has NHS dm+d (dictionary of medicines and devices) VMP (Virtual Medicinal Product) route of administration | Ocular | true | Inferred relationship | Existential restriction modifier | ||
| Product containing precisely hydrocortisone acetate 15 milligram/1 gram and neomycin sulfate 5 milligram/1 gram conventional release ear or eye ointment | Has manufactured dose form | Conventional release ear or eye ointment | false | Inferred relationship | Existential restriction modifier | ||
| Product containing precisely hydrocortisone acetate 15 milligram/1 gram and neomycin sulfate 5 milligram/1 gram conventional release ear or eye ointment | Count of base of active ingredient | 2 | false | Inferred relationship | Existential restriction modifier | ||
| Product containing precisely hydrocortisone acetate 15 milligram/1 gram and neomycin sulfate 5 milligram/1 gram conventional release ear or eye ointment | Has active ingredient | Neomycin sulfate | false | Inferred relationship | Existential restriction modifier | ||
| Product containing precisely hydrocortisone acetate 15 milligram/1 gram and neomycin sulfate 5 milligram/1 gram conventional release ear or eye ointment | Count of base of active ingredient | 2 | false | Inferred relationship | Existential restriction modifier | ||
| Product containing precisely hydrocortisone acetate 15 milligram/1 gram and neomycin sulfate 5 milligram/1 gram conventional release ear or eye ointment | Has manufactured dose form | Conventional release ear or eye ointment | false | Inferred relationship | Existential restriction modifier | ||
| Product containing precisely hydrocortisone acetate 15 milligram/1 gram and neomycin sulfate 5 milligram/1 gram conventional release ear or eye ointment | Has manufactured dose form | Ointment | false | Inferred relationship | Existential restriction modifier | ||
| Product containing precisely hydrocortisone acetate 15 milligram/1 gram and neomycin sulfate 5 milligram/1 gram conventional release ear or eye ointment | Count of base of active ingredient | 2 | false | Inferred relationship | Existential restriction modifier | ||
| Product containing precisely hydrocortisone acetate 15 milligram/1 gram and neomycin sulfate 5 milligram/1 gram conventional release ear or eye ointment | VMP prescribing status (attribute) | VMP valid as a prescribable product | true | Inferred relationship | Existential restriction modifier | ||
| Product containing precisely hydrocortisone acetate 15 milligram/1 gram and neomycin sulfate 5 milligram/1 gram conventional release ear or eye ointment | VMP non-availability indicator | Not available | true | Inferred relationship | Existential restriction modifier | ||
| Product containing precisely hydrocortisone acetate 15 milligram/1 gram and neomycin sulfate 5 milligram/1 gram conventional release ear or eye ointment | Has specific active ingredient | Neomycin sulfate | true | Inferred relationship | Existential restriction modifier | ||
| Product containing precisely hydrocortisone acetate 15 milligram/1 gram and neomycin sulfate 5 milligram/1 gram conventional release ear or eye ointment | Has specific active ingredient | Hydrocortisone acetate | true | Inferred relationship | Existential restriction modifier | ||
| Product containing precisely hydrocortisone acetate 15 milligram/1 gram and neomycin sulfate 5 milligram/1 gram conventional release ear or eye ointment | Has dispensed dose form | Ointment | false | Inferred relationship | Existential restriction modifier | ||
| Product containing precisely hydrocortisone acetate 15 milligram/1 gram and neomycin sulfate 5 milligram/1 gram conventional release ear or eye ointment | Is a | Virtual medicinal product | true | Inferred relationship | Existential restriction modifier | ||
| Product containing precisely hydrocortisone acetate 15 milligram/1 gram and neomycin sulfate 5 milligram/1 gram conventional release ear or eye ointment | Has dispensed dose form | Conventional release eye ointment | true | Inferred relationship | Existential restriction modifier | ||
| Product containing precisely hydrocortisone acetate 15 milligram/1 gram and neomycin sulfate 5 milligram/1 gram conventional release ear or eye ointment | Has manufactured dose form | Conventional release eye ointment | false | Inferred relationship | Existential restriction modifier |
| Inbound Relationships | Type | Active | Source | Characteristic | Refinability | Group |
| Neomycin+hydrocortisone 0.5%/1.5% eye/ear ointment - product | Is a | False | Product containing precisely hydrocortisone acetate 15 milligram/1 gram and neomycin sulfate 5 milligram/1 gram conventional release ear or eye ointment | Inferred relationship | Existential restriction modifier | |
| Neo-Cortef ear/eye ointment (Pliva Pharma Ltd) | Is a | True | Product containing precisely hydrocortisone acetate 15 milligram/1 gram and neomycin sulfate 5 milligram/1 gram conventional release ear or eye ointment | Inferred relationship | Existential restriction modifier | |
| Hydrocortisone 1.5% / Neomycin 0.5% ear/eye ointment 3.9 gram | Is pack of | False | Product containing precisely hydrocortisone acetate 15 milligram/1 gram and neomycin sulfate 5 milligram/1 gram conventional release ear or eye ointment | Inferred relationship | Existential restriction modifier | |
| Hydrocortisone 1.5% / Neomycin 0.5% ear/eye ointment 3.9 gram | Has VMP | True | Product containing precisely hydrocortisone acetate 15 milligram/1 gram and neomycin sulfate 5 milligram/1 gram conventional release ear or eye ointment | Inferred relationship | Existential restriction modifier |
This concept is not in any reference sets
FHIR